• Mashup Score: 0

    Howard Soule joins Charles Ryan to discuss the Coffey-Holden Prostate Cancer Academy, an annual scientific event hosted by the Prostate Cancer Foundation that mixes young and senior investigators to discuss diverse topics faced by men with advanced prostate cancer. The event aims to give young investigators a podium and an opportunity to interact with selected senior investigators. About 80% of…

    Tweet Tweets with this article
    • The Coffey – Holden #ProstateCancer Academy meeting. @soulehoward1 joins @charlesryanmd @PCFnews to discuss this event hosted by the #PCF, mixing young and senior investigators to discuss diverse topics faced by men with advanced prostate cancer > https://t.co/CytbzVaU9b https://t.co/3MeKZ5Ptsp

  • Mashup Score: 0

    Howard Soule joins Charles Ryan to discuss the Coffey-Holden Prostate Cancer Academy, an annual scientific event hosted by the Prostate Cancer Foundation that mixes young and senior investigators to discuss diverse topics faced by men with advanced prostate cancer. The event aims to give young investigators a podium and an opportunity to interact with selected senior investigators. About 80% of…

    Tweet Tweets with this article
    • The Coffey – Holden #ProstateCancer Academy meeting. @soulehoward1 joins @charlesryanmd @PCFnews to discuss this event hosted by the #PCF, mixing young and senior investigators to discuss diverse topics faced by men with advanced prostate cancer > https://t.co/CytbzVaU9b https://t.co/VBSEwSK308

  • Mashup Score: 0

    Howard Soule joins Charles Ryan to discuss the Coffey-Holden Prostate Cancer Academy, an annual scientific event hosted by the Prostate Cancer Foundation that mixes young and senior investigators to discuss diverse topics faced by men with advanced prostate cancer. The event aims to give young investigators a podium and an opportunity to interact with selected senior investigators. About 80% of…

    Tweet Tweets with this article
    • The Coffey – Holden #ProstateCancer Academy meeting. @soulehoward1 joins @charlesryanmd @PCFnews to discuss this event hosted by the #PCF, mixing young and senior investigators to discuss diverse topics faced by men with advanced prostate cancer > https://t.co/CytbzVaU9b https://t.co/vP6shmLa5S

  • Mashup Score: 0

    PCF-Pfizer Health Equity Challenge Award recipient Christina Dieli-Conwright joins Charles Ryan in a discussion on exercise oncology, particularly in prostate cancer. A field of research that is centered around the utilization of exercise or physical fitness to enhance the lives of people diagnosed with cancer or at risk of developing cancer. Dieli-Conwright details on the POWER trial, Exercise…

    Tweet Tweets with this article
    • Exercise oncology in #ProstateCancer, a 2021 #PCF-@Pfizer Health Equity Challenge Award. @ChristinaDieli @DanaFarber joins @charlesryanmd @PCFnews to discuss the #POWER trial in this conversation on UroToday > https://t.co/p71uFq064p @PCF_Science https://t.co/asH8D0KRog

  • Mashup Score: 0

    PCF-Pfizer Health Equity Challenge Award recipient Christina Dieli-Conwright joins Charles Ryan in a discussion on exercise oncology, particularly in prostate cancer. A field of research that is centered around the utilization of exercise or physical fitness to enhance the lives of people diagnosed with cancer or at risk of developing cancer. Dieli-Conwright details on the POWER trial, Exercise…

    Tweet Tweets with this article
    • Exercise oncology in #ProstateCancer, a 2021 #PCF-@Pfizer Health Equity Challenge Award. @ChristinaDieli @DanaFarber joins @charlesryanmd @PCFnews to discuss the #POWER trial in this conversation on UroToday > https://t.co/p71uFq064p @PCF_Science https://t.co/cc38T9bri1

  • Mashup Score: 1

    PCF-Pfizer Health Equity Challenge Award recipient Christina Dieli-Conwright joins Charles Ryan in a discussion on exercise oncology, particularly in prostate cancer. A field of research that is centered around the utilization of exercise or physical fitness to enhance the lives of people diagnosed with cancer or at risk of developing cancer. Dieli-Conwright details on the POWER trial, Exercise…

    Tweet Tweets with this article
    • Exercise oncology in #ProstateCancer, a 2021 #PCF-@Pfizer Health Equity Challenge Award. @ChristinaDieli @DanaFarber joins @charlesryanmd @PCFnews to discuss the #POWER trial in this conversation on UroToday > https://t.co/p71uFq064p @PCF_Science https://t.co/mD09J1MJ29

  • Mashup Score: 3

    Charles Ryan and Howard Soule discuss the progress of the 2022 Prostate Cancer Foundation (PCF) TACTICAL Team Science Award campaign. The TACTICAL campaign, ( T herapy AC celeration T o I ntercept CA ncer L ethality) seeks qualified teams of academic scientists that will specifically address the development of 21st Century therapies for lethal forms of prostate cancer. These awards will be…

    Tweet Tweets with this article
    • Targeting mechanisms of lethal #ProstateCancer, the 2022 #PCF #TACTICAL Team Science Award. @charlesryanmd and @soulehoward1 @PCFnews discuss the progress of this award campaign in a conversation on UroToday > https://t.co/23dRmVEgWg @PCF_Science https://t.co/JRJ3kafVIA

  • Mashup Score: 2

    PCF-Pfizer Health Equity Challenge Award recipient Christina Dieli-Conwright joins Charles Ryan in a discussion on exercise oncology, particularly in prostate cancer. A field of research that is centered around the utilization of exercise or physical fitness to enhance the lives of people diagnosed with cancer or at risk of developing cancer. Dieli-Conwright details on the POWER trial, Exercise…

    Tweet Tweets with this article
    • Exercise oncology in #ProstateCancer, a 2021 #PCF-@Pfizer Health Equity Challenge Award. @ChristinaDieli @DanaFarber joins @charlesryanmd @PCFnews to discuss the #POWER trial in this conversation on UroToday > https://t.co/p71uFq064p @PCF_Science https://t.co/YnYAMYdz6i

  • Mashup Score: 1

    Charles Ryan and Howard Soule discuss the progress of the 2022 Prostate Cancer Foundation (PCF) TACTICAL Team Science Award campaign. The TACTICAL campaign, ( T herapy AC celeration T o I ntercept CA ncer L ethality) seeks qualified teams of academic scientists that will specifically address the development of 21st Century therapies for lethal forms of prostate cancer. These awards will be…

    Tweet Tweets with this article
    • Targeting mechanisms of lethal #ProstateCancer, the 2022 #PCF #TACTICAL Team Science Award. @charlesryanmd and @soulehoward1 @PCFnews discuss the progress of this award campaign in a conversation on UroToday > https://t.co/23dRmVmG4I @PCF_Science https://t.co/rgPP8ggyaH

  • Mashup Score: 1
    Pharma Congress - 2 year(s) ago

    18th Annual Pharmaceutical and Medical Device Compliance Congress. November 6th-8th at the Mandarin Oriental in Washington DC

    Tweet Tweets with this article
    • #PCF #PharmaCongress kicks off tomorrow! Join Deloitte’s Paul Silver at 4:30 p.m. ET on Day 1 as he moderates the Annual Chief Compliance Officer Fireside Chat. https://t.co/ZPLRKQet5K